Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CME (CME)

CME Group reports record 2025 revenue of $6.5 billion; Q4 diluted EPS $3.24

Positive Impact 3 of 5 earnings Written later

On February 4, 2026, CME Group reported fourth-quarter and full-year 2025 results, with full-year revenue of $6.5 billion and operating income of $4.2 billion. Full-year GAAP diluted earnings per share were $11.16, up from $9.67 in 2024, and the company said it was the fourth consecutive year of record annual revenue and adjusted earnings per share.

Key points

  • Fourth-quarter 2025 revenue was $1.6 billion, compared with $1.5 billion in the fourth quarter of 2024.
  • Fourth-quarter 2025 GAAP diluted EPS was $3.24 versus $2.40; adjusted diluted EPS was $2.77 versus $2.52.
  • Full-year 2025 adjusted diluted EPS was $11.20 versus $10.26 in 2024.
  • Record 2025 average daily volume of 28.1 million contracts; Q4 ADV was 27.4 million contracts, up 7% from Q4 2024.

The filing

CompanyCME (CME)
Form8-K, current report
Filed with the SECFeb 4, 2026, 7:06 AM ET
Accession number0001156375-26-000006

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.